Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?

Muhammad Abdul-Ghani

Division of Diabetes

Producción científica: Comment/debate › revisión exhaustiva

44 Citas (Scopus)

Idioma original	English (US)
Páginas (desde-hasta)	373-375
Número de páginas	3
Publicación	Diabetes care
Volumen	38
N.º	3
DOI	https://doi.org/10.2337/dc14-2517
Estado	Published - mar 2015

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Acceder al documento

10.2337/dc14-2517

Otros archivos y enlaces

Citar esto

@article{8bd1083cbd4e440ea4c25e1227be4981,

title = "Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?",

author = "Muhammad Abdul-Ghani",

year = "2015",

month = mar,

doi = "10.2337/dc14-2517",

language = "English (US)",

volume = "38",

pages = "373--375",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "3",

}

TY - JOUR

T1 - Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?

AU - Abdul-Ghani, Muhammad

PY - 2015/3

Y1 - 2015/3

UR - https://www.scopus.com/pages/publications/84940101393

UR - https://www.scopus.com/pages/publications/84940101393#tab=citedBy

U2 - 10.2337/dc14-2517

DO - 10.2337/dc14-2517

M3 - Comment/debate

C2 - 25715413

AN - SCOPUS:84940101393

SN - 0149-5992

VL - 38

SP - 373

EP - 375

JO - Diabetes care

JF - Diabetes care

IS - 3

ER -